C. elegans: An invaluable model organism for the proteomics studies of the cholesterol-mediated signaling pathway

Expert Review of Proteomics

Volumn 3, Issue 4, 2006, Pages 439-453

  Paik, Young Ki ^a   Jeong, Seul Ki ^b   Lee, Eun Young ^b   Jeong, Pan Young ^b   Shim, Yhong Hee ^c  

^a Yonsei University   (South Korea)

^b Yonsei University   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

C. elegans proteome project; Caenorhabditis elegans; Cholesterol mediated signaling pathway; Post translational modification; Protein protein interaction

Indexed keywords

CAENORHABDITIS ELEGANS PROTEIN; CHOLESTEROL; TRANSCRIPTOME;

BIOLOGICAL MODEL; CAENORHABDITIS ELEGANS; CELL GROWTH; CELL MATURATION; CELLULAR DISTRIBUTION; GENE FUNCTION; GENOMICS; HIGH THROUGHPUT SCREENING; NEMATODE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW;

ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CHOLESTEROL; DATABASES, PROTEIN; MODELS, ANIMAL; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; REPRODUCTION; SIGNAL TRANSDUCTION;

CAENORHABDITIS ELEGANS;

EID: 33747184525     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.3.4.439     Document Type: Review

References (98)

1. Riddle D, Albert P. C. elegans II. Riddle D, Blumenthal T, Meyer B, Priess J (Eds). Cold Spring Harbor Laboratory Press, NY, USA, 739-768 (1997). •• Excellent introductory overview of Caenorhabditis elegans works.
2. Lai CH, Chou CY, Ch'ang LY, Liu CS, Lin W. Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res. 10(5), 703-713 (2000).
3. van Helden J. Prediction of transcriptional regulation by analysis of the non-coding genome. Curr. Genomics 4, 217-224 (2003).
4. The C. elegans Sequencing Consortium. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282(5396), 2012-2018 (1998).
5. Brett D, Pospisil H, Valcarcel J, Reich J, Bork P. Alternative splicing and genome complexity. Nat. Genet. 30, 29-30 (2002).
6. Reboul J, Vaglio P, Rual JF et al. C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression. Nat. Genet. 34(1), 35-41 (2003).
7. Huang RY, Boulton SJ, Vidal M et al. High-throughput expression, purification, and characterization of recombinant Caenorhabditis elegans proteins. Biochem. Biophys. Res. Commun. 307(4), 928-934 (2003).
8. Luan CH, Qiu S, Finley JB et al. High-throughput expression of C. elegans proteins. Genome Res. 14(10B), 2102-2110 (2004).
9. Lamesch P, Milstein S, Hao T et al. C. elegans ORFeome version 3.1: increasing the coverage of ORFeome resources with improved gene predictions. Genome Res. 14(10B), 2064-2069 (2004).
10. Chen N, Lawson D, Bradnam K et al. WormBase as an integrated platform for the C. elegans ORFeome. Genome Res. 14(10B), 2155-2161 (2004).
11. Vanfleteren JR, De Vreese A. Analysis of the proteins of aging Caenorhabditis elegans by high resolution two-dimensional gel electrophoresis. Electrophoresis 15(2), 289-296 (1994).
12. Bini L, Heid H, Liberatori S et al. Two-dimensional gel electrophoresis of Caenorhabditis elegans homogenates and identification of protein spots by microsequencing. Electrophoresis 18, 557-562 (1997).
13. Kaji H, Tsuji T, Mawuenyega KG et al. Profiling of Caenorhabditis elegans proteins using two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21(9), 1755-1765 (2000).
14. Schrimpf SP, Langen H, Gomes AV et al. A two-dimensional protein map of Caenorhabditis elegans. Electrophoresis 22(6), 1224-1232 (2001).
15. Madi A, Mikkat S, Ringel B et al. Mass spectrometric proteome analysis for profiling temperature-dependent changes of protein expression in wild-type Caenorhabditis elegans. Proteomics 3(8), 1526-1534 (2003).
16. Bantscheff M, Ringel B, Madi A et al. . Proteomics 4(8), 2283-2295 (2004). • Differential proteome analysis and mass spectrometric characterization of germ line development-related proteins of C. elegans.
17. Mawuenyega KG, Kaji H, Yamuchi Y et al. Large-scale identification of Caenorhabditis elegans proteins by multidimensional liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2(1), 23-35 (2003).
18. Krijgsveld J, Ketting RF, Mahmoudi T et al. Metabolic labeling of C. elegans and D. melanogaster for quantitative Proteomics Nat. Biotechnol. 21(8), 927-931 (2003) • First quantitative proteomics for C. elegans using metabolic labeling.
19. Tabuse Y, Nabetani T, Tsugita A. Proteomic analysis of protein expression profiles during Caenorhabditis elegans development using two-dimensional difference gel electrophoresis Proteomics 5(11), 2876-2891 (2005).
20. Masuda M, Saimaru H, Takamura N et al. An improved method for proteomics studies in C. elegans by fluorogenic derivatization, HPLC isolation, enzymatic digestion and liquid chromatography - tandem mass spectrometric identification. Biomed. Chromatogr. 19(7), 556-560 (2005).
21. Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21(3), 255-261 (2003). • Describes a pioneering work on the post-translational modification analysis by mass spectrometry.
22. Kalume DE, Molina H, Pandey A. Tackling the phosphoproteome: tools and strategies. Curr. Opin. Chem. Biol. 7(1), 64-69 (2003).
23. Jensen ON. Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry. Curr. Opin. Chem. Biol. 8(1), 33-41 (2004).
24. Wang X, Inoue S, Gu J et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc. Natl Acad. Sci. USA 102(44), 15791-15796 (2005).
25. Hirabayashi J, Arata Y, Kasai K. Glycome project: concept, strategy and preliminary application to Caenorhabditis elegans. Proteomics 1(2), 295-303 (2001).
26. Fan X, She YM, Bagshaw RD, et al. Identification of the hydrophobic glycoproteins of Caenorhabditis elegans. Glycobiology 15(10), 952-964 (2005).
27. Schachter H. Protein glycosylation lessons from Caenorhabditis elegans. Curr. Opin. Struct. Biol. 14(5), 607-616 (2004).
28. Fan X, She YM, Bagshaw RD et al. A method for proteomic identification of membrane-bound proteins containing Asn-linked oligosaccharides. Anal. Biochem. 332(1), 178-186 (2004).
29. Kaji H, Isobe T. Protein database of Caenorhabditis elegans. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 787(1), 91-99 (2003).
30. Taniguchi N, Nakamura K, Narimatsu H et al. Human Disease Glycomics/Proteome Initiative Workshop and the 4th HUPO Annual Congress. Proteomics 6(1), 12-13 (2006).
31. Gygi SP, Rist B, Aebersold R. Measuring gene expression by quantitative proteome analysis. Curr. Opin. Biotechnol. 11(4), 396-401 (2000).
32. Cutler P. Protein arrays: the current state-of-the-art. Proteomics 3(1), 3-18 (2003).
33. Li S, Armstrong CM, Bertin N, et al. A map of the interactome network of the metazoan C. elegans. Science 303(5657), 540-543 (2004).
34. Walhout AJ, Reboul J, Shtanko O et al. Integrating interactome, phenome, and transcriptome mapping data for the C. elegans germline. Curr. Biol. 12(22), 1952-1958 (2002).
35. Walhout AJ, Boulton SJ, Vidal M. Yeast two-hybrid systems and protein interaction mapping projects for yeast and worm. Yeast 17(2), 88-94 (2000).
36. Fields S. High-throughput two-hybrid analysis. The promise and the peril. FEBS J. 272(21), 5391-5393 (2005). •• Offers a clear description of all aspects of yeast two-hybrid systems.
37. Duchaine TF, Wohlschlegel JA, Kennedy S et al. Functional proteomics reveals the biochemical niche of C. elegans DCR-1 in multiple small-RNA-mediated pathways. Cell 124(2), 343-354 (2006).
38. Skop AR, Liu H, Yates J III et al. Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms. Science 305(5680), 61-66 (2004).
39. Gilleard JS, Woods DJ, Dow JA. Model-organism genomics in veterinary parasite drug-discovery. Trends Parasitol. 21(7), 302-305 (2005).
40. Olsen A, Vantipalli MC, Lithgow GJ. Using Caenorhabditis elegans as a model for aging and age-related diseases. Ann. NY Acad. Sci. 1067, 120-128 (2006).
41. Kwok TC, Ricker N, Fraser R et al. A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature 441(7089), 91-95 (2006).
42. Lochnit G, Bongaarts R, Geyer R. Searching new targets for anthelminthic strategies: interference with glycosphingolipid biosynthesis and phosphorylcholine metabolism affects development of Caenorhabditis elegans. Int. J. Parasitol. 35(8), 911-923 (2005).
43. Gaud A, Simon JM, Witzel T et al. Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans. Neuromuscul. Disord. 14(6), 365-370 (2004).
44. Jain KK. RNAi and siRNA in target validation. Drug. Discov. Today 9(7), 307-309 (2004).
45. Williams PL, Dusenbery DB. Screening test for neurotoxins using Caenorhabditis elegans. Prog. Clin. Biol. Res. 253, 163-170 (1987).
46. Kimura KD, Tissenbaum HA, Liu Y et al. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277(5328), 942-946 (1997).
47. Patterson GI, Padgett RW. TGF beta-related pathways. Roles in Caenorhabditis elegans development. Trends Genet. 16(1), 27-33 (2000).
48. Jia K, Albert PS, Riddle DL. DAF-9, a cytochrome P450 regulating C. elegans larval development and adult longevity. Development 129(1), 221-231 (2002). •• Demonstrates the involvement of cholesterol-mediated signaling pathway in dauer formation, an important feature in the life cycle of C. elegans.
49. Gerisch B, Antebi A. Hormonal signals produced by DAF-9/cytochrome P450 regulate C. elegans dauer diapause in response to environmental cues. Development 131(8), 1765-1776 (2004).
50. Kurzchalia TV, Ward S. Why do worms need cholesterol? Nat. Cell Biol. 5(8), 684-688 (2003). •• Provides a comprehensive view of the role of cholesterol in C. elegans.
51. Bae S, Seong J, Paik YK. Cholesterol biosynthesis from lanosterol: molecular cloning, chromosomal localization, functional expression and liver-specific gene regulation of rat sterol delta8-isomerase, a cholesterogenic enzyme with multiple functions. Biochem. J. 353, 689-699 (2001).
52. Braverman N, Lin P, Moebius FF et al. Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hunermann syndrome. Nat. Genet. 22, 291-294 (1999).
53. Chitwood DJ. Biochemistry and function of nematode steroids. Crit. Rev. Biochem. Mol. Biol. 34, 273-284 (1999). •• Most extensive review on the molecular aspect of sterols in C. elegans.
54. Lee EY, Shim YH, Chitwood DJ et al. Cholesterol-producing transgenic Caenorhabditis elegans lives longer due to newly acquired enhanced stress resistance. Biochem. Biophys. Res. Commun. 328(4), 929-936 (2005).
55. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 387(6633), 569-572 (1997).
56. Yochem J, Tuck S, Greenwald I, Han M. A gp330/megalin-related protein is required in the major epidermis of Caenorhabditis elegans for completion of molting. Development 126(3), 597-606 (1999).
57. Scheel J, Srinivasan J, Honnert U et al. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans. Nat. Cell Biol. 1(2), 127-129 (1999).
58. Church DL, Guan KL, Lambie EJ. Three genes of the MAP kinase cascade, mek-2, mpk-1/sur-1 and let-60 ras, are required for meiotic cell cycle progression in Caenorhabditis elegans. Development 121, 2525-2535 (1995).
59. Matyash M, Matyash V, Nolte C et al. Requirement of functional ryanodine receptor type 3 for astrocyte migration. FASEB J. 16(1), 84-86 (2002).
60. Schedin P, Jonas P, Wood WB Function of the her-1 gene is required for maintenance of male differentiation in adult tissues of C. elegans. Dev. Genet. 15(3), 231-239 (1994).
61. Thiele C, Hannah MJ, Fahrenholz F et al. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat. Cell Biol. 2(1), 42-49 (2000).
62. Motola DL, Cummins CL, Rottiers V et al. Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans. Cell 124(6), 1209-1223 (2006). •• Landmark paper describing the discovery of ketosteroid molecules as DAF-12 ligands.
63. Michaux G, Gansmuller A, Hindelang C et al. CHE-14, a protein with a sterol-sensing domain, is required for apical sorting in C. elegans ectodermal epithelial cells. Curr. Biol. 10(18), 1098-1107 (2000).
64. Choi BK, Chitwood DJ, Paik YK. Proteomic changes during disturbance of cholesterol metabolism by azacoprostane treatment in Caenorhabditis elegans. Mol. Cell. Proteomics 2(10), 1086-1095 (2003). •• This paper describes the proteomic analysis of disturbance of the cholesterol-mediated signaling pathway with regard to cellular and molecular regulation of cholesterol in C. elegans.
65. Chitwood DJ, Lusby WR, Lozano R, Thompson MJ, Svoboda JA. Novel nuclear methylation of sterols by the nematode Caenorhabditis elegans. Steroids 42, 311-319 (1983).
66. Jeong PY, Jung M, Yim YH et al. Chemical structure and biological activity of the Caenorhabditis elegans dauer-inducing pheromone. Nature 433(7025), 541-545 (2005). •• Landmark paper describing the molecular identity of the dauer-inducing pheromone.
67. Shim YH, Chun JH, Lee EY et al. Role of cholesterol in germ-line development of Caenorhabditis elegans. Mol. Reprod. Dev. 61(3), 358-366 (2002). • Demonstrates that cholesterol is essential for germ-line development in C. elegans.
68. Sternberg PW, Schmid SL. Caveolin, cholesterol and Ras signaling. Nat. Cell Biol. 1(2), E35-E37 (1999).
69. Kuwabara PE, Lee MH, Schedl T et al. C. elegans patched gene, ptc-1, functions in germ-line cytokinesis. Genes Dev. 14(15), 1933-1944 (2000).
70. Shibata Y, Branicky R, Landaverde IO et al. Redox regulation of germline and vulval development in Caenorhabditis elegans. Science 302(5651), 1779-1782 (2003).
71. Reinke V, Smith HE, Nance J et al. A global profile of germline gene expression in C. elegans. Mol. Cell. 6(3), 605-616 (2000). •• Marks the first comprehensive genomic analysis of the C. elegans germline.
72. Steiner S, Gatlin CL, Lennon JJ et al. Proteomics to display lovastatin-induced protein and pathway regulation in rat liver. Electrophoresis 21(11), 2129-2137 (2000).
73. Steiner S, Gatlin CL, Lennon JJ, et al. Cholesterol biosynthesis regulation and protein changes in rat liver following treatment with fluvastatin. Toxicol. Lett. 120(1-3), 369-377 (2001).
74. Park JY, Seong JK, Paik YK. Proteomic analysis of diet-induced hypercholesterolemic mice. Proteomics 4(2), 514-523 (2004).
75. Fenyo D. Identifying the proteome: software tools. Curr. Opin. Biotechnol. 11(4), 391-395 (2000).
76. Costanzo MC, Hogan JD, Cusick ME et al. The yeast proteome database (YPD) and Caenorhabditis elegans proteome database (WormPD): comprehensive resources for the organization and comparison of model organism protein information. Nucleic Acids Res. 28(1), 73-76 (2000).
77. Costanzo MC, Crawford ME, Hirschman JE et al. PombePD and WormPD: model organism volumes of the BioKnowledge library, an integrated resource for protein information. Nucleic Acids Res. 29(1), 75-79 (2001).
78. Kersey P, Bower L, Morris L et al. Integr8 and Genome Reviews: integrated views of complete genomes and proteomes. Nucleic Acids Res. 33(Database issue), D297-D302 (2005).
79. Wu CH, Apweiler R, Bairoch A et al. The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic Acids Res. 34(Database issue), D187-D191 (2006).
80. Mulder NJ, Apweiler R, Attwood TK et al. InterPro, progress and status in 2005. Nucleic Acids Res. 33(Database issue), D201-D205 (2005).
81. Kriventseva EV, Servant F, Apweiler R. Improvements to CluSTr: the database of SWISS-PROT+TrEMBL protein clusters. Nucleic Acids Res. 31(1), 388-389 (2003).
82. Camon E, Magrane M, Barrell D et al. The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res. 32(Database issue), D262-D266 (2004).
83. Valencia A. Automatic annotation of protein function. Curr. Opin. Struct. Biol. 15(3), 267-274 (2005).
84. Kent WJ. BLAT - the BLAST-like alignment tool. Genome Res. 12(4), 656-664 (2002).
85. Hoersch S, Leroy C, Brown NP et al. The GeneQuiz web server: protein functional analysis through the Web. Trends Biochem. Sci. 25(1), 33-35 (2000).
86. Huang Y, Li Y. Prediction of protein subcellular locations using fuzzy k-NN method. Bioinformatics 20(1), 21-28 (2004).
87. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res. 14(11), 4683-4690 (1986).
88. Tsur D, Tanner S, Bafna ZE et al. Identification of post-translational modifications by blind search of mass spectra. Nat. Biotechnol. 23(12), 1562-1567 (2005).
89. Han Y, Ma B, Zhang K. SPIDER: software for protein identification from sequence tags with de novo sequencing error. J. Bioinform. Comput. Biol. 3(3), 697-716 (2005).
90. Searle BC, Dasari S, Turner M et al. High-throughput identification of proteins and unanticipated sequence modifications using a mass-based alignment algorithm for MS/MS de novo sequencing results. Anal. Chem. 76(8), 2220-2230 (2004).
91. Julenius K, Molgaard A, Gupta R et al. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15(2), 153-164 (2005).
92. Xenarios I, Salwinski L, Duan XJ et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res. 30(1), 303-305 (2002).
93. Zanzoni A, Montecchi-Palazzi L, Quondam M et al. MINT: a Molecular INTeraction database. FEBS Lett. 513(1), 135-140 (2002).
94. Bader GD, Betel D, Hogue CW. BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res. 31(1), 248-250 (2003).
95. Oltvai ZN, Barabasi AL. Systems biology. Life's complexity pyramid. Science 298(5594), 763-764 (2002).
96. Titz B, Schlesner M, Uetz P. What do we learn from high-throughput protein interaction data? Expert Rev. Proteomics 1(1), 111-121 (2004).
97. Yu H, Luscombe NM, Lu HX et al. Annotation transfer between genomes: protein-protein interologs and protein-DNA regulogs. Genome Res. 14(6), 1107-1118 (2004).
98. Website 101 Wellcome Trust - Sanger Institute www.sanger.ac.uk/projects/ c.elegans/wormpep